MolNFT v1 · #319649 · protein
AlphaFold monomer V2.0 prediction for pts system mannose-specific eiibca component (O31645)
O31645: “AlphaFold monomer V2.0 prediction for pts system mannose-specific eiibca component (O31645)”. 7 pockets (best druggability 0.45). MolNFT v1 #319649 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- O31645
- Type
- protein
- Length
- 650 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0xf87a97E0A4bB354D834857B14296240B167cbe70
- Molecule
- Pts system mannose-specific eiibca component
- UniProt
- O31645
- Pockets
- 7 · best druggability 0.45
Structure
1 distinct chain · 58% helix, 11% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Pts system mannose-specific eiibca component | protein | 650 | 58% helix, 11% strand | O31645 |
Pockets
7 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 118 | 0.45 | 0.78 | 18 | empty |
| 2 | 214 | 0.44 | 0.73 | 23 | empty |
| 3 | 113 | 0.43 | 0.76 | 15 | empty |
| 4 | 155 | 0.41 | 0.74 | 26 | empty |
| 5 | 51 | 0.37 | 0.80 | 14 | empty |
Compared structures
- 2R48 · Crystal structure of the fructose specific IIB subunit of PTS system from Bacillus… · an experimental structure of the same protein · chain A against A, TM-score 0.16
- 2R48 · Crystal structure of the fructose specific iib subunit of pts system from bacillus… · an experimental structure of the same protein · chain A against A, TM-score 0.16
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O31645
- Elsewhere: UniProt O31645 · AlphaFold DB O31645
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.